AbbVie Inc. (ABBV) Stock Overview
NYSE · Healthcare · Drug Manufacturers - General
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About AbbVie Inc.
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the…
Source: Yahoo Finance
Sector & Industry
AbbVie Inc. operates in the Healthcare sector, within the Drug Manufacturers - General industry group. It is listed on the NYSE exchange.
AbbVie Inc. at a Glance
| Company | AbbVie Inc. |
| Ticker | ABBV |
| Exchange | NYSE |
| Currency | USD |
| Price | $256.46 |
| Market cap | $453.19B |
| P/E ratio (trailing) | 72.45 |
| EPS (trailing) | $3.54 |
| 52-week high | $267.47 |
| 52-week low | $190.75 |
| Dividend yield | 2.70% |
| Ex-dividend date | 15 Jul 2026 |
| Beta | 0.28 |
| Return on equity (ROE) | — |
| Debt-to-equity | — |
| Average volume | 6.38M |
| Shares outstanding | 1.77B |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Employees | 57,000 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
A practical framework for judging whether a dividend is safe and worth owning.
Check Price →Top-rated books on building an income portfolio from dividend payers.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Frequently Asked Questions
- What is AbbVie Inc.'s current P/E ratio?
- AbbVie Inc. (ABBV) has a trailing P/E ratio of 72.45 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is AbbVie Inc.'s market capitalisation?
- AbbVie Inc.'s market cap is $453.19B based on our latest snapshot. See how it ranks by market cap →
- What is ABBV's 52-week range?
- Over the past 52 weeks, ABBV has traded between $190.75 and $267.47. What does the 52-week range mean? →
- How volatile is AbbVie Inc. compared to the market?
- AbbVie Inc. has a beta of 0.28, meaning it has historically moved less than the broader market. What does beta measure? →
- Does AbbVie Inc. pay a dividend?
- AbbVie Inc.'s trailing annual dividend yield is 2.70%. Compare with other high-yield stocks →
- What exchange is ABBV listed on?
- ABBV is listed on the NYSE. Browse all NYSE-listed stocks →
- What sector is AbbVie Inc. in?
- AbbVie Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Need to convert currencies or units alongside this data? Our quick conversion tools are always on hand.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →